serious

Alvara Protocol Raises $2.4M in Lightning Public Round

Source Node:
Time Stamp: March 19, 2024 12:12 PM - Modified On: March 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  Alvara Protocol is looking set to play a substantial role in redefining how the world invests. Their groundbreaking infrastructure, that is set to be an industry first, leverages the ERC-7621 (BTS or Basket Token Standard) to facilitate the creation of fully decentralized tokenized cryptocurrency investment funds. Now, anyone can now become a fund manager with ease. The responsibility for managing funds is something that has long been gatekept. Reserved for institutions or those already financially established. This is no longer the case. Alvara are poised to empower the next

Walking the Tightrope

Source Node:
Time Stamp: November 15, 2023 5:02 AM - Modified On: November 15, 2023 - Published By:
Source Cluster:
Republished By Plato

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Crypto Market Trends – BUSD Launched a Crypto Recovery Fund

Source Node:
Time Stamp: April 26, 2023 7:14 AM - Modified On: April 26, 2023 - Published By:
Source Cluster:
Republished By Plato

2023-4-6 The price volatility that has been experienced in the crypto sector since 2022 has shown the need for stablecoin issuers to hedge against their cryptocurrencies to avert potential disastrous eventualities such as implosions. Still, the market has a clear memory of the impact of the Terra USD crash on the crypto market in particular and the digital sector in general. This article discusses Binance’s initiative to introduce a recovery fund for its stablecoin Binance USD (BUSD). Binance to convert the recovery fund into a few cryptocurrencies Recently, Binance announced

These are the new cryptocurrencies to keep an eye on in 2022

Source Node:
Time Stamp: August 29, 2022 3:56 PM - Modified On: February 26, 2024 - Published By:
Source Cluster:
Republished By Plato

As cryptocurrencies become more mainstream, new cryptocurrencies are popping up on the market every day. 2021 has already been an extremely successful year for cryptocurrencies and once again proved that they are not a dream bubble to be laughed at. There are currently a lot of new cryptocurrencies that are on their way onto the market. Which ones were really worth investing in? Of course, you can only find out about this and more from us. 1. Lucky Block (LBLOCK) Lucky Block could almost be described as an unlicensed casino

How Technology Aids Your Brain When Solving Puzzles

Source Node:
Time Stamp: June 26, 2022 12:06 PM - Modified On: June 26, 2022 - Published By:
Source Cluster:
Republished By Plato

In addition to being enjoyable, solving puzzles requires a serious mental effort. Both families and individuals can enjoy solving puzzles. It doesn't matter if your preferred problem is a 1,000-piece jigsaw, the Sunday crossword puzzle from the New York Times, a wooden brain teaser, or a 3D mechanical puzzle; all puzzles have one thing in common: they stimulate your brain. In the digital age, puzzles are still highly popular, although this trend has a very long history. Since the time of the ancient world, puzzles have appeared in a variety

ADDX Launches Private Market Services For Wealth Managers; StashAway, CGS-CIMB Among The First On Board

Source Node:
Time Stamp: April 7, 2022 10:25 PM - Modified On: April 7, 2022 - Published By:
Source Cluster:
Republished By Plato

Wealth managers can offer clients fractional access to a full suite of private market assets, helping them gain a competitive advantage over platforms with only public market products SINGAPORE, 8 APRIL 2022 – Wealth managers can now introduce more of their end-investors to the world of private investments through a newly-launched institutional service on digital securities exchange ADDX. Corporate treasuries and family offices can also take part in the space via a corporate service to diversify their portfolios through private market products. Both services fall under a new product line